Sincere Capital
11
41M
11
0.44
4
- Areas of investment
Summary
In 1999 was created Sincere Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Shanghai. The company was established in Asia in China.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2017.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Augmented Reality, Software. Among the various public portfolio startups of the fund, we may underline HiScene Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Sincere Capital, startups are often financed by Meitu, GGV Capital, Chuchuang Investment. The meaningful sponsors for the fund in investment in the same round are V Star Capital, Seekdource, Meitu. In the next rounds fund is usually obtained by Yangtze River Delta Collaborative Advantage Industry Fund, Panxi Capital Management, Ondine Capital.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 4
- Rounds per year
- 0.44
- Investments by industry
- Biotechnology (4)
- Pharmaceutical (3)
- Semiconductor (3)
- Manufacturing (3)
- Electronics (3) Show 13 more
- Investments by region
-
- China (10)
- United States (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.82
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mabwell Biotech | 29 Apr 2020 | Biotechnology, Life Science, Biopharma | Early Stage Venture | 278M | China, Shanghai |
| Nation RFID | 01 Sep 2018 | Manufacturing, Electronics, Telecommunications | Seed |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.